In addition,it has gained some success how to treat acute lung injury/acute respiratory distress syndrome(ALI/ARDS) with pulmonary surfactant preparation,however,it is lack of SP-A in exogenous PS preparation that limits the curative effect largely.
此外,在急性肺损伤/急性呼吸窘迫综合症(ALI/ARDS)的治疗方面,PS替代治疗虽已获得了一定成功,但是,因现有外源性PS制剂中缺乏SP-A,使其疗效大受限制。